UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Stillwater Capital Advisors LLC

Stillwater Capital Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 97.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 975 shares of the healthcare conglomerate's stock after selling 34,292 shares during the quarter. Stillwater Capital Advisors LLC's holdings in UnitedHealth Group were worth $511,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of UNH. Capital & Planning LLC increased its stake in UnitedHealth Group by 19.2% in the 4th quarter. Capital & Planning LLC now owns 491 shares of the healthcare conglomerate's stock worth $248,000 after purchasing an additional 79 shares in the last quarter. Brighton Jones LLC grew its stake in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new position in UnitedHealth Group during the 4th quarter valued at about $27,233,000. Revolve Wealth Partners LLC grew its stake in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Finally, Bank Pictet & Cie Europe AG grew its stake in UnitedHealth Group by 3.9% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock valued at $133,373,000 after acquiring an additional 9,872 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UNH opened at $313.39 on Monday. The stock has a market cap of $284.28 billion, a PE ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.44. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The stock's 50 day simple moving average is $386.66 and its 200-day simple moving average is $472.32.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter in the prior year, the firm posted $6.91 earnings per share. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.82%. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio is 37.02%.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on UNH shares. JPMorgan Chase & Co. reduced their price target on UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. HSBC reiterated a "reduce" rating and set a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Truist Financial reiterated a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Finally, Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $426.52.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil bought 3,700 shares of the firm's stock in a transaction dated Thursday, May 15th. The shares were bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the acquisition, the director now owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the firm's stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer now directly owns 203,796 shares of the company's stock, valued at approximately $59,329,091.52. The trade was a 9.20% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last three months. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.